本頁面由Tiger Trade Technology Pte. Ltd.提供服務

4D Molecular Therapeutics

13.17
-0.3200-2.37%
盤後13.170.00000.00%19:56 EDT
成交量:48.12萬
成交額:634.48萬
市值:7.28億
市盈率:-4.78
高:14.02
開:13.69
低:12.94
收:13.49
52周最高:16.93
52周最低:6.47
股本:5,524.42萬
流通股本:4,201.62萬
量比:0.86
換手率:1.15%
股息:- -
股息率:- -
每股收益(TTM):-2.7580
每股收益(LYR):-2.4200
淨資產收益率:-43.25%
總資產收益率:-25.09%
市淨率:1.78
市盈率(LYR):-5.44

資料載入中...

2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/09/18

重要事件披露

Form 8-K - Current report
2024/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/09

重要事件披露

Form 8-K - Current report
2024/07/23

重要事件披露

Form 8-K - Current report
2024/07/17

重要事件披露

Form 8-K - Current report
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]